Literature DB >> 8508529

Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding.

A M Feldman1, E O Weinberg, P E Ray, B H Lorell.   

Abstract

Left ventricular hypertrophy (LVH) is associated with reinduction of the fetal program of gene expression. It is unclear whether this pattern of cardiac gene expression changes with the development of left ventricular decompensation and failure. To answer these questions, we quantified steady-state levels of mRNA by the polymerase chain reaction in the left ventricular myocardium of rats 8 and 20 weeks after ascending aortic banding. Clinical and hemodynamic assessment identified two distinct groups of animals 20 weeks after aortic banding. The first group (20-week nonfailed LVH) demonstrated substantial LVH but no depression in systolic developed pressure per gram left ventricular weight compared with the age-matched control group. In contrast, a second group of rats exhibited clinical signs of congestive failure as well as a marked diminution in left ventricular developed pressure per gram. Assessment of the levels of mRNA encoding a panel of cardiac proteins demonstrated a greater than twofold increase in beta-myosin heavy chain mRNA and an approximately sixfold increase in atrial natriuretic factor mRNA in left ventricular myocardium of all three groups (8-week LVH, 20-week nonfailed LVH, 20-week failed LVH) when compared with appropriate age-matched control groups. In contrast, Ca(2+)-ATPase mRNA levels were decreased by 50% only in the left ventricular myocardium of animals with both clinical signs and hemodynamic indexes consistent with cardiac decompensation (20-week failed LVH). These results suggest that in rats with ascending aortic banding the hypertrophic phenotype is associated with a selective reinduction of the fetal gene program, which persists even after the development of left ventricular failure.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8508529     DOI: 10.1161/01.res.73.1.184

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  65 in total

Review 1.  Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance.

Authors:  K Yamauchi-Takihara; T Kishimoto
Journal:  Int J Exp Pathol       Date:  2000-02       Impact factor: 1.925

2.  Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure.

Authors:  M I Miyamoto; F del Monte; U Schmidt; T S DiSalvo; Z B Kang; T Matsui; J L Guerrero; J K Gwathmey; A Rosenzweig; R J Hajjar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 3.  Molecular and cellular mechanisms of myocardial remodeling.

Authors:  Melanie Maytin; Wilson S Colucci
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

4.  Acute targeting of general transcription factor IIB restricts cardiac hypertrophy via selective inhibition of gene transcription.

Authors:  Danish Sayed; Zhi Yang; Minzhen He; Jessica M Pfleger; Maha Abdellatif
Journal:  Circ Heart Fail       Date:  2014-11-14       Impact factor: 8.790

5.  Sarcoplasmic reticulum Ca2+ regulatory protein gene expression in human right atrium under hemodynamic overload.

Authors:  K Sadamatsu; Y Urabe; H Tsutsui; H Tagawa; F Maruoka; K Igarashi-Saito; K Takeda; Y Kawachi; H Yasui; A Takeshita
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

6.  Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction.

Authors:  Ellen O Weinberg; Masahisa Shimpo; Gilles W De Keulenaer; Catherine MacGillivray; Shin-ichi Tominaga; Scott D Solomon; Jean-Lucien Rouleau; Richard T Lee
Journal:  Circulation       Date:  2002-12-03       Impact factor: 29.690

7.  Heart failure alters matrix metalloproteinase gene expression and activity in rat skeletal muscle.

Authors:  Robson Francisco Carvalho; Rafael Dariolli; Luis Antonio Justulin Junior; Mário Mateus Sugizaki; Marina Politi Okoshi; Antonio Carlos Cicogna; Sérgio Luis Felisbino; Maeli Dal Pai-Silva
Journal:  Int J Exp Pathol       Date:  2006-12       Impact factor: 1.925

8.  Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy.

Authors:  M Sulaiman; M J Matta; N R Sunderesan; M P Gupta; M Periasamy; M Gupta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

9.  Transcriptional regulation patterns revealed by high resolution chromatin immunoprecipitation during cardiac hypertrophy.

Authors:  Danish Sayed; Minzhen He; Zhi Yang; Lin Lin; Maha Abdellatif
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

10.  Development of pressure overload induced cardiac hypertrophy is unaffected by long-term treatment with losartan.

Authors:  M Turcani; H Rupp
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.